Cleared Traditional

K134051 - TRANSONIC ELSA SYSTEM

K134051 is an FDA 510(k) clearance for TRANSONIC ELSA SYSTEM, manufactured by Transonic Systems, Inc.. The device is a Class 2 Cardiovascular device with product code DXG cleared through the Traditional 510(k) pathway after a 394-day FDA review.

K134051 · Transonic Systems, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2015
Decision
394d
Days
Class 2
Risk

K134051 is an FDA 510(k) clearance for the TRANSONIC ELSA SYSTEM. Classified as Computer, Diagnostic, Pre-programmed, Single-function (product code DXG), Class II - Special Controls.

Submitted by Transonic Systems, Inc. (Ithaca, US). The FDA issued a Cleared decision on January 29, 2015 after a review of 394 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1435 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Transonic Systems, Inc. devices

FDA 510(k) Submission Details - K134051

510(k) Number K134051 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 31, 2013
Decision Date January 29, 2015
Days to Decision 394 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
269d slower than avg
Panel avg: 125d · This submission: 394d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXG Device Classification - Class 2, Special Controls

Product Code DXG Computer, Diagnostic, Pre-programmed, Single-function
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1435
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXG Computer, Diagnostic, Pre-programmed, Single-function

All 96
Devices cleared under the same product code (DXG) and FDA review panel - the closest regulatory comparables to K134051.
Hypotension Decision Assist
K190955 · Directed Systems, Ltd. · Nov 2019
Argos
K181372 · Retia Medical, LLC · Dec 2018
PulsioFlex Monitoring System
K172259 · Pulsion Medical Systems SE · Jan 2018
TRANSONIC HCM 103 SYSTEM
K134035 · Transonic Systems, Inc. · Sep 2014
TRANSONIC HCM 102 SYSTEM
K140017 · Transonic Systems, Inc. · Sep 2014
VIGILEO ARTERIAL PRESSURE CARDIAC OUTPUT/OXIMETRY MONITOR
K131588 · Edwards Lifesciences, LLC · May 2014